Agenus Company Profile (NASDAQ:AGEN)

About Agenus

Agenus logoAgenus Inc. (Agenus) is an immuno-oncology company. The Company is engaged in discovering and developing treatments for patients with cancer. Its approaches are driven by platforms and programs, which include antibody discovery platform, including Retrocyte Display, SECANT yeast display and phage display technologies designed to produce human antibodies; antibody candidate programs, including checkpoint modulator (CPM) programs; vaccine programs, including Prophage and AutoSynVax, and saponin-based vaccine adjuvants, principally QS-21 Stimulon adjuvant (QS-21 Stimulon). The Company has a portfolio of programs in various stages of development, including a series of antibodies in discovery and pre-clinical and clinical development, Prophage vaccine, a Heat Shock Protein (HSP)-based vaccine candidate for a form of brain cancer that has completed Phase II trials, and a number of QS-21 Stimulon-containing vaccine candidates in late stage development.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: AGEN
  • CUSIP: 00847G70
Key Metrics:
  • Previous Close: $5.85
  • 50 Day Moving Average: $5.38
  • 200 Day Moving Average: $4.20
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.87
  • P/E Growth: 0.00
  • Market Cap: $511.91M
  • Outstanding Shares: 86,912,000
  • Beta: 2.23
Additional Links:
Companies Related to Agenus:

Analyst Ratings

Consensus Ratings for Agenus (NASDAQ:AGEN) (?)
Ratings Breakdown: 7 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.33 (87.64% upside)

Analysts' Ratings History for Agenus (NASDAQ:AGEN)
DateFirmActionRatingPrice TargetDetails
8/23/2016Jefferies GroupReiterated RatingBuyView Rating Details
7/31/2016HC WainwrightReiterated RatingBuy$10.00View Rating Details
7/28/2016Maxim GroupReiterated RatingBuy$7.00View Rating Details
3/9/2016JPMorgan Chase & Co.Lower Price TargetMarket Outperform$17.00 -> $15.00View Rating Details
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$17.00 -> $15.00View Rating Details
12/31/2015Oppenheimer Holdings Inc.Reiterated RatingPositive -> Outperform$14.00View Rating Details
9/10/2015William BlairReiterated RatingBuyView Rating Details
7/27/2015MLV & Co.Reiterated RatingBuy$9.00 -> $11.00View Rating Details
(Data available from 8/25/2014 forward)


Earnings History for Agenus (NASDAQ:AGEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/28/2016Q216($0.34)($0.33)$5.12 million$6.59 millionViewListenView Earnings Details
4/28/2016Q116($0.23)($0.37)$5.16 millionViewListenView Earnings Details
3/3/2016Q415($0.17)($0.18)$9.39 million$7.64 millionViewListenView Earnings Details
10/27/2015Q315($0.15)($0.16)$7.56 millionViewListenView Earnings Details
7/23/2015Q215($0.15)($0.44)$5.71 million$6.38 millionViewListenView Earnings Details
4/23/2015Q115($0.01)($0.28)$11.66 million$3.95 millionViewN/AView Earnings Details
2/26/2015Q414($0.16)($0.41)$1.62 millionViewN/AView Earnings Details
10/31/2014Q314($0.15)($0.13)$1.96 million$1.56 millionViewN/AView Earnings Details
7/24/2014Q214($0.17)($0.12)$3.07 millionViewN/AView Earnings Details
5/8/2014Q114($0.13)($0.01)$0.55 million$0.72 millionViewN/AView Earnings Details
3/5/2014Q413($0.24)($0.16)$870.00 million$393.00 millionViewN/AView Earnings Details
10/24/2013Q313($0.27)($0.24)$736.00 millionViewN/AView Earnings Details
7/25/2013Q2 2013($0.21)($0.40)ViewN/AView Earnings Details
2/28/2013Q4 2012($0.24)($0.23)$0.72 million$1.09 millionViewN/AView Earnings Details
7/28/2011($0.05)($0.05)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Agenus (NASDAQ:AGEN)
Current Year EPS Consensus Estimate: $-1.27 EPS
Next Year EPS Consensus Estimate: $-1.24 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.18)($0.18)($0.18)
Q2 20161($0.39)($0.39)($0.39)
Q3 20161($0.44)($0.44)($0.44)
Q4 20161($0.47)($0.47)($0.47)
Q1 20171($0.24)($0.24)($0.24)
Q2 20171($0.24)($0.24)($0.24)
Q3 20171($0.25)($0.25)($0.25)
Q4 20171($0.25)($0.25)($0.25)
(Data provided by Zacks Investment Research)


Dividend History for Agenus (NASDAQ:AGEN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Agenus (NASDAQ:AGEN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/9/2016Garo H ArmenCEOBuy100,000$3.18$318,000.00View SEC Filing  
5/5/2016Ozer BaysalInsiderBuy2,250$3.10$6,975.00View SEC Filing  
3/7/2016Garo H ArmenCEOBuy200,000$4.03$806,000.00View SEC Filing  
12/29/2015Garo H. ArmenCEOSell219,576$4.59$1,007,853.84View SEC Filing  
12/28/2015Garo H. ArmenCEOSell134,352$4.60$618,019.20View SEC Filing  
9/25/2015Charles Evan BallantyneCFOBuy10,000$5.05$50,500.00View SEC Filing  
9/25/2015Garo H ArmenCEOBuy100,000$5.03$503,000.00View SEC Filing  
4/29/2015Shahzad MalikDirectorSell1,107,377$7.11$7,873,450.47View SEC Filing  
1/9/2015Qvt Associates Gp LlcMajor ShareholderSell2,343,630$5.31$12,444,675.30View SEC Filing  
1/23/2014Karen ValentineVPSell2,850$3.50$9,975.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Agenus (NASDAQ:AGEN)
News IconAgenus Inc. (NASDAQ:AGEN) earnings expectations - The Independent Republic (NASDAQ:AGEN) - August 25 at 3:22 PM
News IconTop Earnings to Watch for: Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN) - August 25 at 3:22 PM
News IconGlobal vaccine adjuvants market research report - forecast to 2027 explored in latest research (NASDAQ:AGEN) - August 24 at 11:39 AM logoETF’s with exposure to Agenus, Inc. : August 23, 2016 (NASDAQ:AGEN) - August 23 at 3:20 PM
News Icon2 Under-the-Radar Cancer Stocks That are in the Bargain Bin Right Now (NASDAQ:AGEN) - August 20 at 8:14 AM
News IconSell-side is Weighing in on Agenus Inc. (NASDAQ:AGEN) Earnings - Post News (NASDAQ:AGEN) - August 19 at 11:45 AM logo2 Cancer Therapy Stocks That Are Ridiculously Cheap Right Now (NASDAQ:AGEN) - August 18 at 11:41 AM
News IconNews review of 2 biotech stocks: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN) - August 16 at 3:22 PM
News IconVaccine Adjuvants Market worth 769.4 Million USD by 2021 (NASDAQ:AGEN) - August 15 at 10:37 AM
News IconHot Biotech Stocks Recap: Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA), Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN) - August 12 at 3:32 PM logoAGENUS INC Financials (NASDAQ:AGEN) - August 12 at 3:32 PM logoWhy Agenus (AGEN) Stock Might be a Great Pick (NASDAQ:AGEN) - August 12 at 11:55 AM logoWatch These 7 Huge Call Purchases In Friday Trade (NASDAQ:AGEN) - August 12 at 2:53 AM logoResearch Report Initiation on Biotech Stocks -- Agenus, ProNAi Therapeutics, Vanda Pharma, and Genocea Biosciences (NASDAQ:AGEN) - August 11 at 12:34 PM logoETF’s with exposure to Agenus, Inc. : August 11, 2016 (NASDAQ:AGEN) - August 11 at 12:34 PM logoAgenus, Inc. :AGEN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:AGEN) - August 10 at 3:41 PM logoLooking At Recent Analyst Ratings: Eclipse Resources Corp (NYSE:ECR), Agenus Inc (NASDAQ:AGEN) - Review Fortune (NASDAQ:AGEN) - August 9 at 3:59 PM logoUpdated Analysts Rating Report: Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) , Agenus Inc. (NASDAQ:AGEN) - Street Updates (NASDAQ:AGEN) - August 8 at 8:09 AM logoJefferies Maintains Agenus Inc to Buy with Price Target $7.00 ... - Trade Calls (NASDAQ:AGEN) - August 8 at 8:09 AM logoTraders Focused Stocks: Agenus Inc. (NASDAQ:AGEN) , Edwards ... - Street Updates (NASDAQ:AGEN) - August 5 at 8:46 PM logoAgenus Inc. (AGEN) Jumps 9.03% on August 05 - (NASDAQ:AGEN) - August 5 at 8:46 PM
News IconAgenus Inc (NASDAQ:AGEN): That’s How Our Members Are Already up 25% In 3-Week, Buy Call At $4.96 (NASDAQ:AGEN) - August 5 at 3:22 PM
News IconDiscover the Global vaccine adjuvants market forecast to 2021 (NASDAQ:AGEN) - August 5 at 11:45 AM
News IconGlobal Vaccine Adjuvants Sales Market Report to 2021: Brenntag Biosector, Seppic, CSL Limited, Agenus Inc (NASDAQ:AGEN) - August 5 at 11:45 AM logoAGENUS INC Files SEC form 10-Q, Quarterly Report (NASDAQ:AGEN) - August 4 at 9:05 PM logoAgenus Inc. (NASDAQ:AGEN): Updated Analyst Ratings - Review Fortune (NASDAQ:AGEN) - August 4 at 11:53 AM
News IconTime To Put On The Watch List? - Agenus Inc. (NASDAQ:AGEN), Halozyme Therapeutics, Inc. (NASDAQ:HALO) - The Voice Registrar (NASDAQ:AGEN) - August 4 at 11:53 AM logoAnalyst's Focused Stocks: Horizon Pharma plc (NASDAQ:HZNP) , Agenus Inc. (NASDAQ:AGEN) - Street Updates (NASDAQ:AGEN) - August 4 at 11:53 AM logoWill Agenus (AGEN) Continue to Surge Higher? (NASDAQ:AGEN) - August 4 at 11:53 AM logoHere Are Research Reports Worth Watching: Agenus Inc (NASDAQ:AGEN), Immunomedics, Inc. (NASDAQ:IMMU) - Review Fortune (NASDAQ:AGEN) - August 3 at 3:25 PM logoSummary of Analysts Rating: AbbVie Inc. (NYSE:ABBV) , Agenus Inc. (NASDAQ:AGEN) - Street Updates (NASDAQ:AGEN) - August 2 at 3:21 PM
News IconBiotechnology Stocks in Focus: Hemispherx BioPharma, Inc ... - Post Registrar (NASDAQ:AGEN) - August 2 at 3:21 PM
News IconAnalyst Recommendation Worth Stating Today: Agenus Inc (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN) - August 2 at 8:08 AM logoEdited Transcript of AGEN earnings conference call or presentation 28-Jul-16 3:00pm GMT (NASDAQ:AGEN) - August 2 at 8:08 AM
News IconTime To Put On The Watch List? - Agenus Inc. (NASDAQ:AGEN), XOMA Corporation (NASDAQ:XOMA) - The Voice Registrar (NASDAQ:AGEN) - August 1 at 3:21 PM
News IconHC Stocks in Drift: Agenus Inc (NASDAQ:AGEN) Allergan plc Ordinary Shares (NYSE:AGN) - share market updates (press release) (NASDAQ:AGEN) - August 1 at 3:21 PM logoAnalysts Ranking Previews: Cigna Corporation (NYSE:CI) , Agenus Inc. (NASDAQ:AGEN) - Street Updates (NASDAQ:AGEN) - August 1 at 8:08 AM logoIdentifying Analyst Research Reports To Consider: Agenus Inc (NASDAQ:AGEN), XOMA Corp (NASDAQ:XOMA) - Review Fortune (NASDAQ:AGEN) - August 1 at 8:08 AM logoWill Agenus Inc. (NASDAQ:AGEN) Surprise Analysts? - Investor Newswire (NASDAQ:AGEN) - July 30 at 3:27 PM logoJefferies & Co disclosed (NASDAQ:AGEN) Agenus Inc, increasing its price target to $7 earlier today (NASDAQ:AGEN) - July 29 at 8:52 PM
News IconBiotech Stocks To Put On Your Watch List: Agenus Inc. (NASDAQ:AGEN), Adverum Biotechnologies, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:AGEN) - July 29 at 3:21 PM
News IconStock Analysis review: Agenus Inc. (NASDAQ:AGEN) - News Oracle (NASDAQ:AGEN) - July 29 at 3:21 PM logoAgenus Inc. (AGEN) Jumps 9.13% on July 28 - (NASDAQ:AGEN) - July 29 at 3:21 PM logoHC Wainwright Weighs In on Agenus Inc (AGEN) Following 2Q:16 Update - Smarter Analyst (NASDAQ:AGEN) - July 29 at 3:21 PM logoAgenus (AGEN) Posts Narrower than Expected Loss in Q2 (NASDAQ:AGEN) - July 29 at 9:47 AM logoAgenus Inc Earnings Call (Q2 2016) (NASDAQ:AGEN) - July 28 at 4:20 PM logoAgenus Inc.: Agenus Reports Second Quarter 2016 Financial Results and Operational Progress - The Wall Street Transcript (NASDAQ:AGEN) - July 28 at 11:59 AM logoAgenus Inc Earnings Call scheduled for 11:00 am ET today (NASDAQ:AGEN) - July 28 at 11:00 AM logoAgenus (AGEN) Reports Narrower-than-Expected Q2 Loss (NASDAQ:AGEN) - July 28 at 10:43 AM logoAgenus Reports Second Quarter 2016 Financial Results and Operational Progress (NASDAQ:AGEN) - July 28 at 9:08 AM


Agenus (NASDAQ:AGEN) Chart for Thursday, August, 25, 2016

Last Updated on 8/25/2016 by Staff